Earnings Call · Q2 FY2022·2022-08-09

Q2 22EPS +16.67%·Rev n/aQ1 22EPS +13.04%·Rev n/aQ4 21EPS +100.00%*·Rev n/aQ3 21EPS -25.93%·Rev n/a⚠ consensus missing

EXELIXIS, INC. EXEL

Susan Hubbard — Investor Relations or Conference Call Host

Michael Morrissey — President and CEO

Christopher Senner — Chief Financial Officer

Patrick Haley — Executive Vice President of Commercial

Vicki Goodman — Clinical Development Executive

Peter Lamb — Preclinical Pipeline Executive

−7.4%1d on move date−9.5% vs SPY3d−7.5%5d−7.4%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EXEL calls or request research access.

More EXEL calls Browse calls Request research access